GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Redx Pharma PLC (LSE:REDX) » Definitions » Days Sales Outstanding

Redx Pharma (LSE:REDX) Days Sales Outstanding : 4.83 (As of Sep. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Redx Pharma Days Sales Outstanding?

Redx Pharma's average Accounts Receivable for the six months ended in Sep. 2023 was £0.05 Mil. Redx Pharma's Revenue for the six months ended in Sep. 2023 was £1.89 Mil. Hence, Redx Pharma's Days Sales Outstanding for the six months ended in Sep. 2023 was 4.83.

The historical rank and industry rank for Redx Pharma's Days Sales Outstanding or its related term are showing as below:

LSE:REDX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 2.69   Med: 42.21   Max: 143.62
Current: 2.69

During the past 12 years, Redx Pharma's highest Days Sales Outstanding was 143.62. The lowest was 2.69. And the median was 42.21.

LSE:REDX's Days Sales Outstanding is ranked better than
98.77% of 892 companies
in the Biotechnology industry
Industry Median: 72.245 vs LSE:REDX: 2.69

Redx Pharma's Days Sales Outstanding increased from Sep. 2022 (3.25) to Sep. 2023 (4.83).


Redx Pharma Days Sales Outstanding Historical Data

The historical data trend for Redx Pharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redx Pharma Days Sales Outstanding Chart

Redx Pharma Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 143.62 42.21 51.16 26.77 2.69

Redx Pharma Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.51 33.71 3.25 0.95 4.83

Competitive Comparison of Redx Pharma's Days Sales Outstanding

For the Biotechnology subindustry, Redx Pharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Redx Pharma's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Redx Pharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Redx Pharma's Days Sales Outstanding falls into.



Redx Pharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Redx Pharma's Days Sales Outstanding for the fiscal year that ended in Sep. 2023 is calculated as

Days Sales Outstanding (A: Sep. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2022 ) + Accounts Receivable (A: Sep. 2023 )) / count ) / Revenue (A: Sep. 2023 )*Days in Period
=( (0.012 + 0.05) / 2 ) / 4.202*365
=0.031 / 4.202*365
=2.69

Redx Pharma's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding (Q: Sep. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Sep. 2023 )) / count ) / Revenue (A: Sep. 2023 )*Days in Period
=( (0 + 0.05) / 1 ) / 1.891*365 / 2
=0.05 / 1.891*365 / 2
=4.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Redx Pharma  (LSE:REDX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Redx Pharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Redx Pharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Redx Pharma (LSE:REDX) Business Description

Traded in Other Exchanges
N/A
Address
Block 33, Mereside, Alderley Park, Macclesfield, GBR, SK10 4TG
Redx Pharma PLC is a United Kingdom-based biotechnology company focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases. Its product pipeline under development includes Porcupine Inhibitor, ROCK2 Selective Inhibitor, GI-targeted ROCK inhibitor, Pan-RAF Inhibitor, and others. The firm operates geographically in UK and Ireland. Revenue is generated from; Scientific programmes and research collaboration, Research collaboration and Research and preclinical development services. Redx is a clinical-stage biotechnology company focused on the discovery & development of novel, small-molecule, targeted medicines for the treatment of cancer and fibrotic disease and the emerging area of cancer-associated fibrosis.

Redx Pharma (LSE:REDX) Headlines

No Headlines